Universal Infant Hepatitis B Virus (HBV) Vaccination for 35 Years: Moving Toward the Eradication of HBV

被引：25
|
作者：
Chang, Kai-Chi [1 ,2 ]
Chang, Mei-Hwei [1 ,3 ]
Chen, Huey-Ling [1 ,3 ,4 ]
Wu, Jia-Feng [1 ]
Chang, Chin-Hao [5 ]
Hsu, Hong-Yuan [1 ,4 ]
Ni, Yen-Hsuan [1 ,3 ]
机构：
[1] Natl Taiwan Univ, Coll Med & Hosp, Dept Pediat, Taipei, Taiwan
[2] Natl Taiwan Univ, Coll Med, Grad Inst Clin Med, Taipei, Taiwan
[3] Natl Taiwan Univ, Coll Med & Hosp, Hepatitis Res Ctr, Taipei, Taiwan
[4] Natl Taiwan Univ, Coll Med & Hosp, Med Educ & Bioeth, Taipei, Taiwan
[5] Natl Taiwan Univ, Coll Med & Hosp, Med Res, Taipei, Taiwan
来源：
JOURNAL OF INFECTIOUS DISEASES | 2022年 / 225卷 / 03期
关键词：
hepatitis B; mother-to-infant transmission; occult HBV infection; vaccination; HEPATOCELLULAR-CARCINOMA; INFECTION; CHILDREN; TRANSMISSION; SEROEPIDEMIOLOGY; IMMUNIZATION; ADOLESCENTS; PROGRAM; TAIWAN;
D O I：
10.1093/infdis/jiab401
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
A universal hepatitis B virus (HBV) vaccination program has been implemented in Taiwan since 1984. A total of 1611 individuals in Taipei were enrolled to monitor long-term efficacy. The prevalences of hepatitis B surface antigen (HBsAg) and hepatitis B core antibody in the vaccinated birth cohort were lower than in those born before 1984 (0.4% vs 7.7%, and 2.2% vs 50.8%, respectively; P < .0001). Three vaccine-failure carriers all were born to HBsAg-carrier mothers, probably due to no antiviral intervention during pregnancy. Occult HBV infection was rare in the postvaccination era. High vaccination coverage, comprehensive HBV screening, and antiviral agents for pregnant mothers will be essential to eliminate HBV transmission. Universal hepatitis B virus (HBV) vaccination effectively prevented chronic HBV infection. High vaccination coverage, comprehensive screening, and antiviral agents for pregnant mothers are essential to eliminate its perinatal transmission and for future elimination.
引用
收藏
页码：431 / 435
页数：5
相关论文
共 50 条
  • [41] Hepatitis B virus prevalence in first-time blood donors in Flanders, Belgium: Impact of universal vaccination and migration
    De Brier, Niels
    Koc, Ozgur M.
    De Buck, Emmy
    Muylaert, An
    Nevens, Frederik
    Vanbrabant, Miek
    Vandeloo, Judith
    Van Remoortel, Hans
    Robaeys, Geert
    Compernolle, Veerle
    TRANSFUSION, 2021, 61 (07) : 2125 - 2136
  • [42] The reliability of HBV core antibody in serological screening for hepatitis B virus
    Ba Alawi, Fatma
    Robertson, Peter W.
    LePage, Amelia K.
    Jayamaha, Jude
    Baleriola, Cristina
    Rawlinson, William D.
    PATHOLOGY, 2013, 45 (05) : 501 - 505
  • [43] Increased risk of developing chronic HBV infection in infants born to chronically HBV infected mothers as a result of delayed second dose of hepatitis B vaccination
    Tharmaphornpilas, Piyanit
    Rasdjarmrearnsook, Aim-orn
    Plianpanich, Saowanee
    Sa-nguanmoo, Pattaratida
    Poovorawan, Yong
    VACCINE, 2009, 27 (44) : 6110 - 6115
  • [44] Moving Fast Toward Hepatitis B Virus Elimination
    Bassit, Leda
    Ono, Suzane Kioko
    Schinazi, Raymond F.
    ANTIVIRAL DRUG DISCOVERY AND DEVELOPMENT, 2021, 1322 : 115 - 138
  • [45] A significant reduction in hepatitis B virus infection among the children of Shandong Province, China: the effect of 15 years of universal infant hepatitis B vaccination
    Zhang, Li
    Xu, Aiqiang
    Yan, Bingyu
    Song, Lizhi
    Li, Manshi
    Xiao, Zuokui
    Xu, Qing
    Li, Liming
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2010, 14 (06) : E483 - E488
  • [46] Clinical Features and Hepatitis B Virus (HBV) Genotypes in Pregnant Women Chronically Infected with HBV
    Michitaka, Kojiro
    Hiraoka, Atsushi
    Imai, Yusuke
    Utsunomiya, Hiroki
    Tatsukawa, Haruka
    Shimizu, Yuko
    Ninomiya, Keiko
    Yamago, Hiroka
    Tanihira, Tetsuya
    Hasebe, Aki
    Ninomiya, Tomoyuki
    Horiike, Norio
    Abe, Masanori
    Hiasa, Yoichi
    Onji, Morikazu
    Abe, Emiko
    Ochi, Hiroshi
    INTERNAL MEDICINE, 2012, 51 (24) : 3317 - 3322
  • [47] Prevalence of hepatitis B virus infection and carriage after nineteen years of vaccination program in the Western Brazilian Amazon
    Miranda Braga, Wornei Silva
    Castilho, Marcia da Costa
    Borges, Fabiane Giovanella
    de Souza Martinho, Ana Cristina
    Rodrigues, Ivo Seixas
    de Azevedo, Eliete Pereira
    Scazufca, Marcia
    Menezes, Paulo Rossi
    REVISTA DA SOCIEDADE BRASILEIRA DE MEDICINA TROPICAL, 2012, 45 (01) : 13 - 17
  • [48] Hepatitis B virus (HBV) reactivation in an acute lymphoblastic leukemia patient despite being vaccinated against HBV in infancy
    Yamamoto, Masayo
    Ikuta, Katsuya
    Sawada, Koji
    Shindo, Motohiro
    Torimoto, Yoshihiro
    Okumura, Toshikatsu
    DIGESTIVE AND LIVER DISEASE, 2019, 51 (10) : 1487 - 1488
  • [49] Assessing Physicians' Recommendations for Hepatitis B Virus (HBV) and Hepatitis C Virus (HCV) Testing Among Minority Populations in Greater Philadelphia and New York City
    Begum, Thoin F.
    Patil, Vidya S.
    Zhu, Lin
    Yeh, Ming-Chin
    Gonzalez, Evelyn
    Fraser, Marilyn A.
    Lu, Wenyue
    Zhu, Steven
    Rubio-Torio, Nathaly
    Ma, Grace X.
    Tan, Yin
    JOURNAL OF COMMUNITY HEALTH, 2024, 49 (04) : 588 - 597
  • [50] Hepatitis B vaccination: A completed schedule enough to control HBV lifelong? Milan, Italy, 17-18 November 2011
    FitzSimons, David
    Hendrickx, Greet
    Vorsters, Alex
    Van Damme, Pierre
    VACCINE, 2013, 31 (04) : 584 - 590
12345